Blood Test Using Exosome RNA to Help Diagnose Prostate Cancer
Tests whether an RNA combination from blood can help diagnose prostate cancer in adults.
Plain-language title generated from the registry record
Registry title: Plasma Exosome RNA to Diagnose Prostate Cancer
Key facts
- Where
- Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, and Yinchuan, ChinaSee the 9 sites
Where in China
- The First Hospital of Lanzhou UniversityLanzhou, ChinaNo longer taking part
- Weinan Central HospitalWeinan, ChinaNo longer taking part
- Shaanxi provincial people's hospitalXi'an, ChinaNo longer taking part
- Xijing 986 HospitalXi'an, ChinaNo longer taking part
- Xijing hospitalXi'an, ChinaNo longer taking part
- The Second Affiliated Hospital of Shaanxi University of Chinese MedicineXianyang, ChinaNo longer taking part
- Qinghai university affiliated hospitalXining, ChinaNo longer taking part
- Affiliated Hospital of Yan'an UniversityYan’an, ChinaNo longer taking part
- General Hospital of Ningxia Medical UniversityYinchuan, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT06604130
- Record updated
- 30 July 2026
- Original description
The aim of the present study is to investigate a RNA combination to diagnose prostate cancer.Read full original descriptionShow less
Plasma Exosome RNA Combination for Diagnosing Prostate Cancer: a Prospective, Multicenter Diagnostic Trial
The aim of the present study is to investigate a RNA combination to diagnose prostate cancer.
Inclusion: Blood prostate-specific antigen PSA\>4ng/dl; Patients suspected of having prostate cancer through clinical symptoms, digital rectal examination, ultrasound examination, magnetic resonance imaging, and PSMA PET/CT examination; The patient is willing to undergo prostate biopsy.
Exclusion: Previous diagnosis of prostate cancer through prostate biopsy; History of other malignant tumors in the past two years; According to the research physician\'s judgment, serious complications may occur and affect the normal conduct of the experiment.